Join Now

Fluidx Medical Announces First Tumor Patient Treated in Prospective, Multinational Trial

Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses.

Posted in BioUtah News | Tagged | Comments Off on Fluidx Medical Announces First Tumor Patient Treated in Prospective, Multinational Trial

Fluidx Unveils New Embolic for Neurovascular Use

New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain

Posted in BioUtah News | Tagged | Leave a comment

Multi-Center Liquid Embolic Study Concludes

Completion of Trial is a Sign of Things to Come for Novel Embolic Agent

Posted in BioUtah News | Tagged | Leave a comment

New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models

Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses

Posted in BioUtah News | Tagged | Leave a comment

Metastatic Tumor Treatment with Novel GPX Embolic Device

Innovative Embolic Device by Fluidx Medical Used Successfully in a Variety of Complex Cancer Cases

Posted in BioUtah News | Tagged | Leave a comment

Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage

Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity

Posted in BioUtah News | Tagged , | Leave a comment

GPX Embolic Device Success in Challenging Tumor Case

Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors

Posted in BioUtah News | Tagged , | Leave a comment

Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor

Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry

Posted in BioUtah News | Tagged , | Leave a comment

Fluidx Medical Technology’s Innovative Embolic Tumor Treating Device Highlighted in “BEST of GEST” Session at the Global Embolization Oncology Symposium Technologies (“GEST”) Conference

Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting.

Posted in BioUtah News | Tagged , | Leave a comment